Imatinib Completed Phase N/A Trials for Leukemia, Myeloid, Chronic-Phase (CML-CP)

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT01188278Treatment With Second Generation Tyrosine Kinase Inhibitors (2G TKI) Post Imatinib Failure Survey